Bionoid Pharma Inc.
BINP
$0.08
$0.000.00%
OTC PK
| 03/31/2012 | 03/31/2011 | ||||
|---|---|---|---|---|---|
| Net Income | -- | -163.35% | |||
| Total Depreciation and Amortization | -- | -16.46% | |||
| Total Amortization of Deferred Charges | -- | -100.00% | |||
| Total Other Non-Cash Items | -- | 246.75% | |||
| Change in Net Operating Assets | -- | -32.72% | |||
| Cash from Operations | -- | -210.28% | |||
| Capital Expenditure | -- | -32.73% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -32.73% | |||
| Total Debt Issued | -- | -105.59% | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | 381.81% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -- | 256.74% | |||
| Foreign Exchange rate Adjustments | -- | -45.45% | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -- | 2,837.76% | |||